Recent data suggested that propranolol suppressed colorectal cancer cell growth through simultaneously activating autologous CD8+ T cells and decreasing the phosphorylation level of mitogen-activated protein kinase (MAPK)/(ATP-dependent tyrosine kinases) AKT pathway (7). This evidence concerns the gene AKT1 and colorectal cancer.